
Larry Biegelsen
Stock Analyst at Wells Fargo
(4.32)
# 1,397
Out of 5,152 analysts
1379
Total ratings
54.9%
Success rate
5.2%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Upgraded: Buy | $113 → $123 | $103.32 | +19.05% | 45 | Nov 17, 2026 | |
| EW Edwards Lifesciences | Rated: Buy | $113 → $121 | $105.23 | +14.99% | 67 | Nov 16, 2026 | |
| AVR Anteris Technologies Global | Rated: Buy | $16 | $5.21 | +207.10% | 6 | Nov 13, 2026 | |
| HTFL HeartFlow | Rated: Buy | $39 → $70 | $45.89 | +52.54% | 5 | Nov 13, 2026 | |
| NPCE NeuroPace | Downgraded: Hold | $19 → $9 | $8.22 | +9.49% | 14 | Nov 13, 2026 | |
| SWX: ALC Alcon Inc. | Rated: Buy | CHF 71.84 | CHF 62.32 | +15.27% | 35 | Nov 11, 2026 | |
| NVCR NovoCure | Reiterated: Hold | $15 | $10.73 | +39.79% | 45 | Nov 10, 2026 | |
| BDX Becton, Dickinson and Company | Upgraded: Buy | $157 → $242 | $216.08 | +12.00% | 41 | Nov 6, 2026 | |
| ENOV Enovis | Rated: Buy | $33 → $37 | $27.10 | +36.53% | 7 | Nov 6, 2026 | |
| GMED Globus Medical | Rated: Buy | $99 → $100 | $70.53 | +41.78% | 14 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $70 → $95 | $86.48 | +9.85% | 4 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $144 → $172 | $139.98 | +22.87% | 41 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $17.05 | +46.63% | 32 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9 → $6 | $5.01 | +19.76% | 27 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 → $69 | $58.11 | +18.74% | 40 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $12 | $7.06 | +69.97% | 3 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $25 | $26.16 | -4.43% | 37 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $46 → $49 | $48.01 | +2.06% | 4 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $14.33 | +95.39% | 2 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $120 | $104.48 | +14.85% | 118 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $13 | $13.86 | -6.20% | 16 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $487 → $486 | $420.95 | +15.45% | 62 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $282 → $287 | $272.70 | +5.24% | 101 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $28.29 | -1.03% | 7 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $82.52 | +9.06% | 66 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $56.95 | -15.72% | 4 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $50 → $48 | $43.64 | +9.99% | 52 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $20.95 | -14.08% | 60 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $318.15 | +9.38% | 41 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $66 → $61 | $60.75 | +0.41% | 45 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 | $100.72 | +3.26% | 91 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $16.99 | +53.03% | 5 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 | $83.66 | +1.60% | 29 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $320.60 | +16.66% | 48 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $74 → $83 | $85.93 | -3.41% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $138 → $178 | $233.08 | -23.63% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $116 → $138 | $165.85 | -16.79% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $280 → $270 | $242.61 | +11.29% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.69 | n/a | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5449 | n/a | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $102.00 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $6.74 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $155.21 | n/a | 1 | Jan 4, 2010 |
Zimmer Biomet Holdings
Nov 17, 2026
Upgraded: Buy
Price Target: $113 → $123
Current: $103.32
Upside: +19.05%
Edwards Lifesciences
Nov 16, 2026
Rated: Buy
Price Target: $113 → $121
Current: $105.23
Upside: +14.99%
Anteris Technologies Global
Nov 13, 2026
Rated: Buy
Price Target: $16
Current: $5.21
Upside: +207.10%
HeartFlow
Nov 13, 2026
Rated: Buy
Price Target: $39 → $70
Current: $45.89
Upside: +52.54%
NeuroPace
Nov 13, 2026
Downgraded: Hold
Price Target: $19 → $9
Current: $8.22
Upside: +9.49%
Alcon Inc.
Nov 11, 2026
Rated: Buy
Price Target: CHF 71.84
Current: CHF 62.32
Upside: +15.27%
NovoCure
Nov 10, 2026
Reiterated: Hold
Price Target: $15
Current: $10.73
Upside: +39.79%
Becton, Dickinson and Company
Nov 6, 2026
Upgraded: Buy
Price Target: $157 → $242
Current: $216.08
Upside: +12.00%
Enovis
Nov 6, 2026
Rated: Buy
Price Target: $33 → $37
Current: $27.10
Upside: +36.53%
Globus Medical
Nov 6, 2026
Rated: Buy
Price Target: $99 → $100
Current: $70.53
Upside: +41.78%
Nov 6, 2026
Rated: Hold
Price Target: $70 → $95
Current: $86.48
Upside: +9.85%
Nov 5, 2026
Reiterated: Hold
Price Target: $144 → $172
Current: $139.98
Upside: +22.87%
Nov 5, 2026
Reiterated: Buy
Price Target: $27 → $25
Current: $17.05
Upside: +46.63%
Nov 4, 2026
Rated: Hold
Price Target: $9 → $6
Current: $5.01
Upside: +19.76%
Nov 2, 2026
Reiterated: Hold
Price Target: $56 → $69
Current: $58.11
Upside: +18.74%
Oct 30, 2026
Rated: Buy
Price Target: $14 → $12
Current: $7.06
Upside: +69.97%
Oct 30, 2026
Reiterated: Hold
Price Target: $19 → $25
Current: $26.16
Upside: -4.43%
Oct 29, 2026
Rated: Hold
Price Target: $46 → $49
Current: $48.01
Upside: +2.06%
Oct 28, 2026
Reiterated: Buy
Price Target: $28
Current: $14.33
Upside: +95.39%
Oct 23, 2026
Reiterated: Buy
Price Target: $112 → $120
Current: $104.48
Upside: +14.85%
Oct 22, 2026
Rated: Hold
Price Target: $15 → $13
Current: $13.86
Upside: -6.20%
Oct 21, 2026
Rated: Buy
Price Target: $487 → $486
Current: $420.95
Upside: +15.45%
Oct 15, 2026
Reiterated: Buy
Price Target: $282 → $287
Current: $272.70
Upside: +5.24%
Oct 15, 2026
Reiterated: Buy
Price Target: $28
Current: $28.29
Upside: -1.03%
Oct 14, 2026
Reiterated: Buy
Price Target: $90
Current: $82.52
Upside: +9.06%
Oct 2, 2026
Reiterated: Buy
Price Target: $48
Current: $56.95
Upside: -15.72%
Sep 24, 2026
Rated: Hold
Price Target: $50 → $48
Current: $43.64
Upside: +9.99%
Sep 18, 2026
Reiterated: Hold
Price Target: $18
Current: $20.95
Upside: -14.08%
Sep 16, 2026
Rated: Buy
Price Target: $348
Current: $318.15
Upside: +9.38%
Sep 9, 2026
Reiterated: Hold
Price Target: $66 → $61
Current: $60.75
Upside: +0.41%
Sep 9, 2026
Reiterated: Buy
Price Target: $104
Current: $100.72
Upside: +3.26%
Sep 8, 2026
Reiterated: Buy
Price Target: $26
Current: $16.99
Upside: +53.03%
Aug 25, 2026
Rated: Buy
Price Target: $85
Current: $83.66
Upside: +1.60%
Aug 3, 2026
Reiterated: Hold
Price Target: $374
Current: $320.60
Upside: +16.66%
Jul 31, 2026
Rated: Hold
Price Target: $74 → $83
Current: $85.93
Upside: -3.41%
Jul 30, 2026
Rated: Buy
Price Target: $138 → $178
Current: $233.08
Upside: -23.63%
May 8, 2026
Reiterated: Hold
Price Target: $116 → $138
Current: $165.85
Upside: -16.79%
Jan 30, 2026
Reiterated: Hold
Price Target: $280 → $270
Current: $242.61
Upside: +11.29%
Nov 13, 2025
Reiterated: Hold
Price Target: $3
Current: $2.69
Upside: n/a
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.5449
Upside: n/a
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $102.00
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $6.74
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $155.21
Upside: n/a